Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidya Mave

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
JAMA Network Open|March 25, 2025
Risk Factors for Health Care-Associated Bloodstream Infections in NICUsJulia Johnson, Sudhir Malwade, Sharad Agarkhedkar, et al.
Frontiers in Tuberculosis|April 30, 2025
Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohortsSonya Krishnan, Nikhil Gupte, Mandar Paradkar, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 4, 2019
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patientsRajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, et al.
Plos One|August 2, 2018
Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden settingPadmapriyadarsini Chandrasekaran, Vidya Mave, Kannan Thiruvengadam, et al.
Annals of the American Thoracic Society|December 1, 2023
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment OutcomesMandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, et al.
Open Forum Infectious Diseases|July 28, 2022
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden SettingsAmita Gupta, Xin Sun, Sonya Krishnan, et al.
The Lancet. Microbe|July 4, 2024
Implications of subclinical tuberculosis for vaccine trial design and global effectGavin J Churchyard, Rein M G J Houben, Katherine Fielding, et al.
Frontiers in Pediatrics|January 24, 2022
Implementation of the Comprehensive Unit-Based Safety Program to Improve Infection Prevention and Control Practices in Four Neonatal Intensive Care Units in Pune, IndiaJulia Johnson, Asad Latif, Bharat Randive, et al.
HIV Medicine|September 26, 2024
Long-term risk of mortality and loss to follow-up in children and adolescents on antiretroviral therapy in AsiaSmita Nimkar, Aarti Kinikar, Vidya Mave, et al.
The Journal of Infectious Diseases|December 5, 2019
Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian ChildrenJeffrey A Tornheim, Anil K Madugundu, Mandar Paradkar, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
JAMA Network Open|March 25, 2025
Risk Factors for Health Care-Associated Bloodstream Infections in NICUsJulia Johnson, Sudhir Malwade, Sharad Agarkhedkar, et al.
Frontiers in Tuberculosis|April 30, 2025
Clinical and laboratory risk factors for pulmonary tuberculosis recurrence in three pooled Indian cohortsSonya Krishnan, Nikhil Gupte, Mandar Paradkar, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 4, 2019
MAL adaptor (TIRAP) S180L polymorphism and severity of disease among tuberculosis patientsRajagopalan Saranathan, Pattabiraman Sathyamurthi, Kannan Thiruvengadam, et al.
Plos One|August 2, 2018
Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden settingPadmapriyadarsini Chandrasekaran, Vidya Mave, Kannan Thiruvengadam, et al.
Annals of the American Thoracic Society|December 1, 2023
Early Microbiologic Markers of Pulmonary Tuberculosis Treatment OutcomesMandar Sudhir Paradkar, Neeta Nitin Pradhan, Subramanyam Balaji, et al.
Open Forum Infectious Diseases|July 28, 2022
Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden SettingsAmita Gupta, Xin Sun, Sonya Krishnan, et al.
The Lancet. Microbe|July 4, 2024
Implications of subclinical tuberculosis for vaccine trial design and global effectGavin J Churchyard, Rein M G J Houben, Katherine Fielding, et al.
Frontiers in Pediatrics|January 24, 2022
Implementation of the Comprehensive Unit-Based Safety Program to Improve Infection Prevention and Control Practices in Four Neonatal Intensive Care Units in Pune, IndiaJulia Johnson, Asad Latif, Bharat Randive, et al.
HIV Medicine|September 26, 2024
Long-term risk of mortality and loss to follow-up in children and adolescents on antiretroviral therapy in AsiaSmita Nimkar, Aarti Kinikar, Vidya Mave, et al.
The Journal of Infectious Diseases|December 5, 2019
Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response Among Indian ChildrenJeffrey A Tornheim, Anil K Madugundu, Mandar Paradkar, et al.
Pageof 15